login
login

Europe Daily Bulletin No. 8739

2 July 2004
Contents Publication in full By article 46 / 49
ECONOMIC INTERPENETRATION / (eu) pharmaceuticals

The German BAYER is in exclusive talks with a view to buying ROCHE's "self medication" arm, valued at around 2.4 billion CHF. This division's turnover was 1.77 billion CHF in 2003. BAYER's turnover was 1.4 billion EUR on this market in 2003.

Contents

A LOOK BEHIND THE NEWS
THE DAY IN POLITICS
GENERAL NEWS
ECONOMIC INTERPENETRATION